Ventyx Biosciences(VTYX)
SAN DIEGO, CABiotechnology
Focus: Ventyx Biosciences is a publicly traded immunology-focused biotech company headquartered in San Diego, specializing in therapeutics targeting innate and adaptive immune systems. The company is currently in clinical development stage with no approved products generating revenue.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Ventyx Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Ventyx Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VTX958
Crohn DiseaseClinical Trials (1)
NCT05688852VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease
Phase 2Help build intelligence for Ventyx Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.